SPRY2 and colorectal carcinoma: In this regard, several other potential epigenetic modifications of SPRY2 have yet to be thoroughly explored in CRC, including changes in DNA 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) deposition.